The application discloses an L-aspartate alpha-decarboxylase with improved substrate tolerance, and the L-aspartate alpha-decarboxylase is derived from
Bacillus subtilis and is subjected to site-directed
mutation, i.e.,
phenylalanine at the 4th site is changed into
tryptophan,
isoleucine at the 33rd site is changed into
alanine, and
isoleucine at the 88th site is changed into
tryptophan, so as to obtain an
enzyme mutant; the
mutant is recombined into E. coli, and after expression is induced, the
mutant catalyzes the substrate L-aspartate to generate beta-
alanine. When the substrate addition concentration of the
whole cell catalytic
system is 60 g / L, the conversion rates of the three
enzyme mutants T4W, I33A and I88M can reach about 90%, and the yields are 1.2, 1.3 and 1.2 times of that of the unmutated strain respectively, and the substrate tolerance is obviously improved; the combined
mutation also has a certain improvement on the substrate tolerance, and the finding has important research value for industrial preparation of beta-
alanine.